跳至主要内容
临床试验/NCT06664710
NCT06664710招募中不适用

Evaluation of the Automated Integration of a Robotics and ECochG System for Use With Cochlear Implant Surgery

iotaMotion, Inc.2 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2024年1月17日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
10
试验地点
2
主要终点
Device Feasibility

研究概览

简要总结

Evaluation of the Automated Integration of a Robotics and ECochG System for Use with Cochlear Implant Surgery

详细描述

The purpose of this study is to evaluate the feasibility and proof of concept of the integration of the AIM System and iotaSOFT Insertion System during cochlear implantation. Study results will help inform the need for future clinical investigations and data collection in the area of ECochG and robotic-assisted cochlear implantation.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Device Feasibility
盲法
None

入排标准

年龄范围
12 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Cochlear implant candidate in one or two ears per current FDA indications
  • Sufficient residual hearing to support use of electrocochleography, as determined by the investigator
  • Cochlear implantation using the Advanced Bionics SlimJ electrode array
  • 18 years of age or older at the time of enrollment
  • Willingness to participate in and comply with all requirements of the protocol

排除标准

  • Contraindications for a CI.
  • Prior cochlear implantation in the ear to be implanted.
  • Cochlear ossification or malformation (including but not limited to dysplasia or common cavity), craniofacial abnormality or any other structural cochlear abnormality that might prevent complete insertion of the electrode array or present an increased risk of aberrant insertion.
  • History of temporal bone fracture that involves the cochlea/internal auditory canal.
  • Retrocochlear etiology (e.g. diagnosis of auditory neuropathy, cochlear nerve deficiency, or lesions of the acoustic nerve or central auditory pathway).
  • Active middle-ear infection or tympanic membrane perforation in the presence of active middle ear disease.
  • Planned or current participation in a clinical study of an investigational device or drug that may impact data collection or outcomes related to this investigation.
  • Additional medical concerns that would prevent participation in evaluations as determined by the investigator.
  • Unrealistic expectations on the part of the subject, regarding the possible benefits, risks, and limitations that are inherent to the procedure and investigational device.
  • Vulnerable subject, as per FDA regulations 21 CFR Parts 50 and 56

结局指标

主要结局

Device Feasibility

时间窗: Procedure Day 0

Feasibility of device functionality intraoperatively at the time of cochlear implant surgery.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验